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Abstract We searched for genes with expressions speci¢c to
human monocyte-derived dendritic cells (DCs) using di¡erential
display reverse transcription-polymerase chain reaction, and
found that N-myc downstream regulated gene 2 (NDRG2), a
member of a new family of di¡erentiation-related genes, was
expressed in DCs. While DCs derived from CD34+ progenitor
cells also showed strong NDRG2 expression, the corresponding
mRNA expression was absent in other cell lines including mono-
cytes, B cells, and NK cells. The inhibition of DC di¡erentiation
by dexamethasone or vitamin D3 treatment down-regulated the
expression of the NDRG2 gene in DCs. In addition, gene ex-
pression was induced in a myelomonocytic leukemia cell line,
which is capable of di¡erentiating into DCs in cytokine-condi-
tioned culture. The level of NDRG2 gene expression in DCs was
signi¢cantly higher than that of other members of the NDRG
gene family. Finally, in contrast to the stable NDRG2 expres-
sion in CD40-stimulated DCs, the induction of DC maturation
by lipopolysaccharide (LPS) resulted in the down-regulation of
NDRG2 gene expression. This down-regulation is likely to be
due to a modi¢cation and subsequent destabilization of NDRG2
mRNA, because co-treating with actinomycin D and LPS sig-
ni¢cantly blocked this LPS e¡ect. Taken together, our results
indicate that NDRG2 is expressed during the di¡erentiation of
DCs, and that NDRG2 gene expression is di¡erentially regu-
lated by maturation-inducing stimuli.
5 2003 Federation of European Biochemical Societies. Pub-
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1. Introduction
Dendritic cells (DCs) are highly specialized antigen-present-
ing cells, and are present in peripheral lymphoid and non-
lymphoid organs. Their unique T-cell stimulatory capacity is
due to the expression of high levels of costimulatory mole-
cules, which include CD40, CD80, and CD86, and of major
histocompatibility complex class I and II antigens that are
essential for the presentation of endogenous and exogenous
protein antigens and for the production of T-cell stimulatory
cytokines such as interleukin-12 (IL-12), IL-15, and IL-18 [1^
3]. In addition, the immune response may be regulated by the
ability of T-cells and various other stimuli to enhance the
survival of DCs and prevent their apoptosis [4,5].
The phenotypic and functional characteristics of DCs are
intimately linked to their stage of maturation, which can be
induced by CD40 stimulation or lipopolysaccharide (LPS), a
component of the Gram-negative microbial cell wall product.
Furthermore, cytokines such as tumor necrosis factor-K
(TNF-K) or IL-1L, and reagents such as metrizamide and
immune complex also induce the maturation of DCs. To bet-
ter understand DC maturation at the molecular level, various
basic studies have been performed upon DC surface molecules
[6^8], gene expression [9^12] and signal transduction pathways
[13,14]. However, the speci¢c biochemical pathways and genes
that mediate the di¡erentiation and maturation of progenitors
to DCs remain largely unde¢ned.
The search for induced genes in the di¡erentiation of hem-
atopoietic precursors is the subject of intensive investigation.
For example, a number of transcription factors involved in
lymphoid lineage speci¢cation in progenitor cells have been
identi¢ed. GATA-3 and Pax5 are essential for T- and B-cell
development, respectively [15,16], whereas Notch1 is required
for T-cell development but inhibits B-cell development, and
therefore, determines T/B-cell diversi¢cation [17]. Moreover,
the helix-loop-helix (HLH) factor Id2 is essential for develop-
ment of natural killer (NK) cells [18]. Further, it has been
reported that basic HLH factors are involved in development
of plasmacytoid DCs (pDC), but not in the development of
myeloid DCs, and that the transcription factor Spi-B is also
involved in the control of pDC development and inhibits T-,
B-, and NK cell development [19^21].
In this study, we searched for genes that were speci¢cally
transcribed during DC di¡erentiation. To this end we utilized
the di¡erential display polymerase chain reaction (DD-PCR)
method and analyzed the gene expression of a monocytic cell
line, DCs, and mature DCs. One of the genes identi¢ed is the
N-myc downstream regulated gene 2 (NDRG2), which be-
longs to a new family of di¡erentiation-related genes.
2. Materials and methods
2.1. Reagents for cell culture, cytokines and antibodies
All cultures were performed in RPMI 1640 medium (Sigma, St.
Louis, MO, USA) supplemented with L-glutamine (2 mM), penicillin
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(100 U/ml), streptomycin (100 Wg/ml), HEPES (10 mM), and 10%
fetal bovine serum (FBS; Gibco BRL, Grand Island, NY, USA).
The growth factors used in the primary cultures of DC precursors
were recombinant human granulocyte-macrophage colony-stimulating
factor (rhGM-CSF; kindly provided by LG LS, Iksan, South Korea)
and recombinant human IL-4 (rhIL-4; Endogen, Woburn, MA,
USA). Dexamethasone and vitamin D3 (1K,25-dihyroxyvitamin D3,
VD3) were purchased from Sigma. Other chemicals were from Sigma
unless noted otherwise. The cytokine-dependent human myelomono-
cytic leukemia cell line MUTZ-3 (DSMZ, Braunschweig, Germany)
was maintained in 10 ng/ml of recombinant human stem cell factor
(rhSCF; RpD Systems, Minneapolis, MN, USA) in 6-well plate (Co-
star, Cambridge, MA, USA), and di¡erentiation into MUTZ-3 DCs
was induced by culture with rhGM-CSF (400 ng/ml), rhIL-4 (20 ng/
ml) and rhTNF-K (2.5 ng/ml; PeproTech, Rochy Hill, NJ, USA) for
4 days. Human agonistic CD40 monoclonal antibody (mAb) was
a⁄nity-puri¢ed from ascites of BALB/c mice immunized with G28.5
hybridoma (HB-9110, ATCC, Rockville, MD, USA), which secreted a
mouse mAb (IgG1) binding to the human CD40 molecule. In order to
induce DC maturation, DCs were stimulated with agonistic CD40
mAb or LPS (1 Wg/ml; Escherichia coli O127-B8, Sigma) for 16 h.
Flow cytometric analysis was used to determine the antigen expression
of human DCs using the following mAbs of mouse origin: £uorescein
isothiocyanate (FITC)-conjugated CD1a, phycoerythrin (PE)-conju-
gated CD11c, PE-conjugated CD80, PE-conjugated CD83, PE-conju-
gated CD86, puri¢ed CD40 (PharMingen, San Diego, CA, USA),
FITC-conjugated CD54 (Immunotech, Marseille, France), FITC-con-
jugated CD14 and FITC-conjugated HLA-DR (Becton Dickinson,
Mountain View, CA, USA). FITC-conjugated goat F(abP)2 anti-
mouse immunoglobulin (Biosource International, Camarillo, CA,
USA) was used as an isotype control or as a secondary reagent.
2.2. Generation of dendritic cells in vitro
For human monocyte-derived DC generation, we used a modi¢ca-
tion of the method described by Sallusto et al. [22]. Brie£y, peripheral
blood mononuclear cells (PBMC) were isolated from the blood of
healthy donors (Red Cross Blood Center, Daejeon, South Korea)
by density centrifugation on Histopaque 1077 (Sigma). After lysing
erythrocytes, cells were resuspended in culture medium and allowed to
adhere to a T-75 culture £ask (Costar) for 2^3 h. Plastic-adherent cells
were cultured overnight and non-adherent cells were removed. Plastic-
adherent monocytes that showed high CD14 expression and were
negative for CD1a were cultured in DC medium containing rhGM-
CSF (400 ng/ml) and rhIL-4 (20 ng/ml). The medium was replaced
with fresh DC medium after 4 days. Human monocyte-derived DCs
were usually harvested after 6^7 days, counted, and used in this study.
For generation of DCs from human CD34þ cells, CD34þ progenitor
cells were isolated from umbilical cord blood (School of Medicine,
Eulji University, Daejeon, South Korea) using a MACS isolation kit
(Miltenyi Biotec, Bergisch Gladbach, Germany), according to the
manufacturer’s instructions. Isolated CD34þ progenitor cells (2U106
cells/2 ml) were cultured in RPMI 1640 with 10% FBS in the presence
of rhGM-CSF (400 ng/ml), rhTNF-K (2.5 ng/ml) and rhSCF (20 ng/
ml) until day 5. SCF was then replaced with IL-4 (20 ng/ml) over the
following 7^9 days. After a total of 12^14 days of culture, CD34þ cell-
derived DCs were harvested and used in this study.
2.3. Flow cytometric analysis
DCs generated by in vitro culture were subjected to £ow cytometric
analysis using FACSCalibur (Becton Dickinson), and data were ana-
lyzed using CellQuest software (Becton Dickinson). Cells were incu-
bated with various FITC- or PE-conjugated mAbs on ice for 30 min
at 4‡C. After washing twice with cold phosphate-bu¡ered saline (pH
7), cells were analyzed by £ow cytometry. Rat IgG1-PE isotype con-
trol (Becton Dickinson) was used as an isotype control. FITC or PE
£uorescence was measured using 530-nm and 575-nm ¢lters with log-
arithmic mode acquisition.
2.4. Proliferation assay of allogeneic PBMC
PBMC (1U105) were incubated with graded numbers of irradiated
(3000 rad) MUTZ-3 or MUTZ-3 DCs. Experiments were performed
in each well of 96-well round-bottom plates. Cell proliferation during
the last 18 h of the 5-day culture was quanti¢ed by measuring the
thymidine uptake of cells incubated with 1 WCi of [methyl-
3H]thymidine (Amersham Pharmacia, Piscataway, NJ, USA). Cells
were harvested onto glass ¢ber ¢lters and radioactivity was measured
using a scintillation counter. Results are presented as mean cpm of
cultures performed in triplicate.
2.5. Isolation of total RNA
Total RNA was extracted from the cultured cells by the acid gua-
nidinium thiocyanate^phenol^chloroform extraction method [23]. To-
tal RNA was dissolved in 0.1% diethylpyrocarbonate (Sigma)-treated
water. The amount of RNA was determined by measuring spectro-
metric absorbance at 260 nm. For determination of the exact RNA
concentration, equal amounts of RNA were loaded on a 0.9% RNA
gel in 1UMOPS bu¡er, and the 18S ribosomal RNA bands were
compared.
2.6. Reverse transcriptase (RT)-PCR analysis
First-strand cDNA was synthesized from total RNA in an RNase-
free condition. The reaction was performed with 10 Wg of total RNA
using a ProSTAR1 First-Strand RT-PCR kit (Stratagene, La Jolla,
CA, USA), according to the manufacturer’s instructions. PCR was
performed in a GeneAmp PCR system 2700 (Perkin-Elmer/Cetus,
Norwalk, CT, USA) using the ¢rst-strand cDNA and Taq polymerase
(TaKaRa Shuzo, Kyoto, Japan) as follows for each primer: NDRG1,
5P-GGTTCCAGCGTCACTTCT-3P and 3P-CTTTCTAGATGCAC-
CAACTT-5P ; NDRG2, 5P-AATGGCCCTTGTTGCCCT-3P and 3P-
TCCTTCCCCACACTCGTT-5P ; NDRG3, 5P-ACCAGACCATG-
GAGGTGT-3P and 3P-CTCTCTATGTAACAGGCAC-5P ; NDRG4,
5P-TTGAAGCCCTTGATCCCG-3P and 3P-TCCAGATGATTGT-
CACATGT-5P ; tapasin, 5P-TTCAACCCTTTCAGGAGG-3P and 3P-
TACTACAGAAGCTTGGGC-5P ; L-actin, 5P-GCCATGTACGTT-
GCTATCCAGGCTG-3P and 3P-AGCCGTGGCCATCTCTTGCTC-
GAAG-5P. PCR-ampli¢ed products were separated on 1.5% agarose
gels containing 0.1 Wg/ml ethidium bromide and visualized under UV
light.
2.7. Northern blot analysis
Northern blot analysis was performed according to a previously
described method [24]. Brie£y, total RNA was separated in a 1%
denaturing formaldehyde^agarose gel, and transferred to a nylon
membrane (Boehringer Mannheim, Mannheim, Germany). After UV
¢xation, the membrane was hybridized at 68‡C in ExpressHyb1 so-
lution (Clontech, Palo Alto, CA, USA) with the complementary DNA
(cDNA) probes labeled with [32P]dCTP (Perkin-Elmer) using a ran-
dom primer DNA labeling kit (Roche, Mannheim, Germany). In the
case of NDRG2, a cDNA probe was prepared from the RT-PCR
product using a speci¢c primer set: 5P-ATGGCGGAGCTGCAGG-
3P and 3P-TCAACAGGAGACCTCCAT-5P. The probed membrane
was then washed in 2Usodium saline citrate and 0.1% sodium dodecyl
sulfate at room temperature, and exposed to autoradiographic ¢lm
using an intensifying screen at 370‡C for 2 to 3 days.
3. Results
3.1. Monocyte-derived DCs express the NDRG2 gene
DCs di¡erentiated from monocytes showed high levels of
CD1a, CD54, CD80, CD86 and HLA-DR expression, but did
not express CD83, indicating an immature DC phenotype.
However, after stimulation with anti-CD40 antibody (1 Wg/
ml), they showed CD83 antigen expression as well as in-
creased levels of CD54, CD86 and HLA-DR antigen expres-
sion (data not shown). In order to search for gene expression
in DCs, DD-RT-PCR was performed on the U937 cell line,
monocyte-derived DCs, and agonistic anti-CD40 antibody-
stimulated DCs. One of the di¡erentially expressed genes
was found to be the NDRG2 gene, which was not expressed
in U937 cells, but was expressed signi¢cantly in DCs when
expression levels were compared using Northern blotting (Fig.
1A). Its expression in DCs was not further increased by CD40
antibody stimulation. DCs are known to strongly express the
tapasin gene that is involved in the processing of class I anti-
gen [25,26]. As expected, DCs, but not U937 cells, expressed
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tapasin, and this expression was enhanced after CD40-in-
duced maturation, suggesting that the RNA prepared from
cells contained representative transcripts.
We wondered whether blood mononuclear cells and mono-
cytes similarly express NDRG2, but found no NDRG2 ex-
pression (Fig. 1B). Interestingly, NDRG2 was also expressed
in DCs obtained by culture of CD34þ cells derived from cord
blood for 2 weeks. Its expression in monocyte-derived DCs
was evident after 2 days and signi¢cantly increased thereafter
(Fig. 1C). In addition, NDRG2 was not detected in leukemia,
lymphoma, B-lymphocyte and NK cell lines (Fig. 1D). These
¢ndings suggest that NDRG2 may be induced during DC
di¡erentiation from precursor cells, because NDRG2 was
not detected in blood mononuclear cells or in several lym-
phoid/myeloid cell lines. In order to examine the possibility
that cytokines are responsible for NDRG2 gene expression,
leukemic cell lines with hematopoietic or monocytic lineages,
which were previously described to be further di¡erentiated in
response to GM-CSF [27], were cultured under the same con-
dition as DCs, and tested for NDRG2 mRNA expression. As
shown in Fig. 1E, no induction of NDRG2 gene expression
was observed, even after treatment with cytokines for 6 days.
Thus, the absence of NDRG2 expression in primary blood
cells and in several other cell lines and the inability of cyto-
kines to induce NDRG2 suggest that NDRG2 expression is
related to the di¡erentiation of DCs.
3.2. Induction of NDRG2 expression during DC di¡erentiation
In order to investigate NDRG2 expression in CD34þ cell-
derived DCs, DCs were generated from cord blood cells by in
vitro culture for 12^13 days in the presence of cytokine com-
binations. DCs di¡erentiated from CD34þ progenitor cells
expressed several DC-related marker antigens on their surfa-
ces at high levels, including CD1a, CD11c, CD40, CD54,
CD80 and HLA-DR, but were negative for CD8, CD14,
CD83 and CD86 antigen expression (Fig. 2A). During the
di¡erentiation process, dendrite formation increased after
1 week of culture, and the morphological features of the
Fig. 1. Expression of NDRG2 mRNA is restricted to monocyte-
and cord blood cell-derived DCs. A: Total RNA (5 Wg) isolated
from U937 cells, DCs (symbol: C) or anti-CD40 antibody-stimu-
lated DCs (KCD40) was blotted and hybridized to a 32P-labeled
NDRG2-speci¢c probe. The expression of tapasin in DCs was used
as a positive control. B: NDRG2 mRNA expression was deter-
mined in PBMC, primary monocytes, monocyte-derived DCs and
CD34-positive cord blood cell-derived DCs. C: RNA was extracted
from DCs cultured for 2, 4 or 7 days, and NDRG2 expression was
determined. D: Total RNA isolated from a variety of human cell
lines and primary cells was hybridized to a 32P-labeled NDRG2
probe. Independent experiments were repeated three times and rep-
resentative autoradiographs are shown. E: Human leukemic cell
lines (HL-60, U937 and THP-1) were cultured in medium containing
GM-CSF (400 ng/ml) and IL-4 (20 ng/ml). After 3 and 6 days, the
cultured cells were harvested and total RNA was isolated from the
cultured cells.
Fig. 2. Expression of NDRG2 mRNA in CD34þ cell-derived DCs.
A: Isolated CD34-positive cells were cultured in the presence of
GM-CSF, TNF-K and SCF followed by IL-4 over the following 7^9
days, and induced to di¡erentiate into DCs. After 12 days surface
antigen expression was measured by immunostaining with the re-
spective antibodies by £ow cytometry (thin line, antibody or non-
stained control; bold line, staining with respective antibodies).
B: Light microscopic images of cultured cells during the di¡erentia-
tion process in the presence of the cytokine combination. C: RNA
was extracted from monocyte-derived DCs or cord blood CD34-
positive cells cultured for 3, 7 or 12 days, and NDRG2 expression
was analyzed by Northern blotting.
Fig. 3. Dendritic cell di¡erentiation of MUTZ-3 cells leads to the
expression of NDRG2. A: MUTZ-3 cells were induced to di¡erenti-
ate by adding cytokine-conditioned medium. After 4 days, surface
antigen expression on di¡erentiated cells (bold line) was compared
with the undi¡erentiated parent cells (thin line) by £ow cytometry.
Shaded histograms show the staining of cells with control antibody.
B: Allogeneic PBMC (1U105) were incubated with the indicated
numbers of parent MUTZ-3 or MUTZ-3 DCs di¡erentiated with
the cytokine combination for 5 days. Cell proliferation was mea-
sured by the incorporation of radioactive thymidine in a scintillation
counter. C: Phase contrast microscopy of undi¡erentiated MUTZ-3
cells and MUTZ-3 DCs after 4 days of di¡erentiation. D: MUTZ-3
cell line did not express NDRG2, whereas MUTZ-3 DCs strongly
expressed the NDRG2 gene. Northern blot using a NDRG2-speci¢c
probe was performed with RNA obtained from primary DCs, par-
ent MUTZ-3 and MUTZ-3 DCs. E: NDRG2 expression during the
DC di¡erentiation of MUTZ-3 cells. Total RNA was isolated from
MUTZ-3 cells at the indicated times during di¡erentiation into
MUTZ-3 DCs.
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DC population were evident on day 12 (Fig. 2B). In parallel
with this observation, cells that had been negative for
NDRG2 gene expression at the beginning of the cultures pro-
gressively expressed the NDRG2 gene (Fig. 2C).
We next examined whether NDRG2 expression could be
induced during the DC di¡erentiation of the myelomonocytic
leukemia cell line MUTZ-3 [28]. When these cells were incu-
bated in the presence of GM-CSF, IL-4 and TNF-K for
4 days, CD1a and CD80 antigen expressions were newly in-
duced in addition to the increased expressions of CD40, CD86
and HLA-DR (Fig. 3A). Morphologic features including the
development of characteristic dendritic cell processes clearly
showed the gaining of the DC phenotype (Fig. 3C). More-
over, when MUTZ-3 DCs were incubated with allogeneic
PBMC, signi¢cant T-cell stimulatory activity was observed,
whereas parent MUTZ-3 cells only stimulated very weakly
(Fig. 3B). These results suggest that MUTZ-3 leukemia cells
in cytokine-conditioned media have the unique ability to ac-
quire the DC phenotype. Importantly, it was notable that
similar to primary DCs, high levels of NDRG2 expression
were observed after DC phenotype induction (Fig. 3D).
Northern blot analysis using the RNA of cells harvested at
several time points demonstrated that gene expression, which
began to appear 48 h after culture, gradually increased in
parallel with the development of DC morphology (Fig. 3E).
These results, therefore, provide evidence that the modulation
of NDRG2 expression may be correlated with the acquisition
of the characteristic DC phenotype.
3.3. Down-regulation of NDRG2 gene expression by the
inhibition of DC di¡erentiation
Dexamethasone and VD3 have been described to a¡ect the
function of DCs by inhibiting NF-UB-induced transcription
and NF-UB activation, respectively, and to inhibit DC di¡er-
entiation [29,30]. When DCs were cultured in the presence of
dexamethasone and VD3, they, in fact, showed low levels of
CD1a expression and signi¢cantly increased levels of CD14
expression, as compared with controls (Fig. 4A). Importantly,
NDRG2 mRNA levels were reduced in dexamethasone- or
VD3-treated DCs (Fig. 4B), indicating that the inhibition of
DC di¡erentiation a¡ects the induction of NDRG2 gene ex-
pression. However, this result does not rule out the possibility
that dexamethasone or VD3 directly a¡ects NDRG2 gene
expression in DCs.
3.4. E¡ect of maturation-inducing stimuli on NDRG2 gene
expression
We examined whether the NDRG2 expression induced dur-
ing DC di¡erentiation is a¡ected by culturing DCs with anti-
CD40 mAb or LPS for 16 h. These conditions led to the
induction of CD83 expression, although it was relatively
low, in CD34þ cell-derived DCs (Fig. 5A), and increased
the expressions of costimulatory molecules (data not shown).
Importantly, CD40-mediated stimulation did not a¡ect ele-
vated NDRG2 gene expression, whereas LPS treatment
strongly inhibited NDRG2 gene expression (Fig. 5B). In con-
trast, DCs treated with TNF-K or IL-1L, which also induces
DC maturation, displayed high NDRG2 expression, at the
same level as the untreated controls, indicating that the LPS
e¡ect on NDRG2 expression was not due to the production of
TNF-K or IL-1L by LPS treatment.
3.5. Expression of NDRG family genes in DCs and the
di¡erential e¡ect of CD40 or LPS stimulation on
NDRG2 mRNA expression
The NDRG gene family currently consists of four members
and is highly conserved in plants, invertebrates and mammals,
so underlining the importance of this gene family. When the
expression levels of the NDRG family in U937 cells and
monocyte-derived DCs were compared by Northern blotting,
it was observed that while NDRG1 and NDRG3 were mod-
erately expressed in both cell types, NDRG4 transcripts could
not be detected in U937, DCs or anti-CD40 mAb-stimulated
DCs (Fig. 6A). The expressions of NDRG1, 3, and 4 genes
were una¡ected by CD40 or LPS stimulation (Fig. 6B). In
addition, the expression of NDRG genes, including
NDRG2, was una¡ected by treatment with TNF-K, IL-1L
or interferon-Q (IFN-Q).
The time course of NDRG2 down-regulation after inducing
the maturation of monocyte-derived DCs with LPS was fol-
lowed to investigate the mechanism further and to provide
information on mRNA stability. Decreased amounts of
NDRG2 mRNA were detected within 6 h of LPS treatment,
and the down-regulation of expression was more signi¢cant
after 12 h (Fig. 6C). We examined whether transcription was
Fig. 4. NDRG2 expression is down-regulated by the inhibition of
DC di¡erentiation. A: Monocyte-derived DCs were generated in the
absence or presence of 1038 M dexamethasone or VD3 and surface
antigen expression on day 7 was determined by £ow cytometry. The
shaded histogram shows control antibody-stained or non-stained
cells. B: Total RNA was obtained from DCs cultured in the ab-
sence (symbol: C) or presence of 1038 M dexamethasone or VD3.
NDRG2 mRNA expression was detected by Northern blotting.
L-Actin was used as a loading control.
Fig. 5. LPS treatment decreases NDRG2 expression. Monocyte- or
CD34þ cell-derived DCs were stimulated with anti-CD40 mAb (1 Wg/
ml) or LPS (1 Wg/ml) for 16 h. A: The surface expression of CD83
was compared on control cells by immunostaining and £ow cyto-
metric analysis (¢lled histogram, unstimulated DCs; open histo-
gram, stimulated DCs). B: DCs were stimulated with anti-CD40
mAb (1 Wg/ml), LPS (1 Wg/ml), TNF-K (100 ng/ml), IFN-Q (1000
U/ml) or IL-1L (10 ng/ml) for 16 h. Total RNA was isolated from
unstimulated or stimulated DCs and NDRG2 mRNA expression
was detected by Northern blotting.
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required in the NDRG2 response to LPS by treating cells with
actinomycin D. In the presence of actinomycin D, NDRG2
mRNA decreased in a time-dependent manner, but it was
detectable for at least 12 h (Fig. 6D). However, actinomycin
D treatment before LPS addition prevented the NDRG2
mRNA attenuation observed in the presence of LPS alone
and gene expression was still maintained at high levels 12 h
after LPS treatment (Fig. 6E). Therefore, this result demon-
strated that the inhibition of NDRG2 mRNA expression by
LPS could be regulated at the transcriptional level.
4. Discussion
In this report, we demonstrate that NDRG2 mRNA is
strongly expressed in primary DCs, including monocyte- and
CD34þ cell-derived DCs, and in leukemic DCs originating
from a myelomonocytic leukemia cell line. NDRG2 mRNA
was not detected in DC precursor cells (e.g. monocytes),
CD34þ precursor cells, or the MUTZ-3 leukemia cell line.
However, NDRG2 mRNA was gradually induced in DCs
that were cultured to di¡erentiate in vitro. In other cell lines
including leukemia, lymphoma, B lymphocyte and NK cell
lines, NDRG2 was not detected, which is consistent with a
study which found that NDRG2 is essentially expressed in the
brain, heart, skeletal muscle, and kidney [31]. To our knowl-
edge, the present study is the ¢rst to indicate that NDRG2
gene expression can be induced in cancer cells and in normal
cells of hematopoietic origin.
NDRG2 belongs to the NDRG family, a new family of
di¡erentiation-related genes. This family comprises four re-
cently identi¢ed members: NDRG1^4 [32]. NDRG1 was ¢rst
observed in various tissues in di¡erent species [33^36]. More-
over, human NDRG members are highly homologous, except
for their C- and N-terminal regions, and exhibit distinct pat-
terns of expression during development and adult life. Where-
as NDRG1 is a widely expressed gene, NDRG2 and NDRG3
are essentially expressed in the brain, heart, skeletal muscle,
and kidney, and NDRG4 expression is restricted to the brain
and heart [31]. In fact, in the present study, we found that the
cells examined did not express NDRG4 mRNA at a detect-
able level, unlike the other NDRG family members. The dis-
tinct expression patterns of the four members of the NDRG
family suggest that they have di¡erent but related functions in
di¡erent tissues and organs. However, the exact functional
role of the NDRG genes remains to be identi¢ed. Accumu-
lated data suggest that NDRG1 plays a role in growth arrest
and cell di¡erentiation, and that it could act as a signaling
protein by shuttling between the cytoplasm and the nucleus.
Indeed, NDRG1 expression has been found to be up-regu-
lated during cell di¡erentiation [34,35,37,38] and repressed
during cell transformation [36] and by N-myc or c-myc [39],
known to inhibit terminal di¡erentiation and to stimulate cell
proliferation. In terms of the other members of the NDRG
family, no information exists on the functions of NDRG2,
NDRG3, and NDRG4, though their expression patterns ap-
pear to be under spatiotemporal regulation, which di¡erenti-
ate them from NDRG1, and suggests that they have speci¢c
functions.
Here we report that the DC di¡erentiation of precursor
cells strongly induces NDRG2 gene expression. The results
of the in vitro experiments suggest that gene expression might
be involved in the regulation of the acquisition of DC mor-
phological characteristics such as dendrite development or a
myeloid DC speci¢cation. In fact, a recent ¢nding suggests
that the NDRG4 protein may participate in regulating pro-
cesses that lead to cellular di¡erentiation and neurite forma-
tion in PC12 cells [40]. The present study shows that cytokines
present in DC culture are not responsible for NDRG2 gene
induction, as cytokine-responsive myelocytic cell lines stimu-
lated with cytokines do not show increased NDRG2 expres-
sion.
The inhibition of DC di¡erentiation by the synthetic gluco-
corticoid dexamethasone or VD3 made it possible to investi-
gate NDRG2 expression during the DC di¡erentiation pro-
cess. Previous studies have demonstrated that NF-UB is
involved in the generation and maturation of DCs [41] and
the inhibition of NF-UB activation down-regulates cytokine
production by DCs and their surface antigen expression
both in the basal state and after LPS activation [13,42]. Inter-
estingly, the inhibition of DC di¡erentiation was found to be
well correlated with reduced NDRG2 expression. Therefore, it
is evident that NDRG2 mRNA is speci¢cally expressed dur-
ing the DC di¡erentiation of monocytes and of puri¢ed
CD34þ cells, although it remains to be seen whether the mol-
ecule is crucial for the development or the progression of DC
di¡erentiation. In the present study, we were not able to rule
out the possibility that NDRG2 expression is directly modu-
lated by NF-UB. However, we found no signi¢cant di¡erences
in the expression level of NDRG2 in mature DCs stimulated
with CD40 antibody or TNF-K, both of which can activate
NF-UB [43]. In addition, it was recently shown that the glu-
cocorticoid dexamethasone is ine¡ective at inducing NDRG2
expression in a rat kidney model [44].
Fig. 6. E¡ects of several maturation-inducing stimuli on NDRG
gene expression. A: After overnight stimulation of DCs, total RNA
(5 Wg) isolated from cells was hybridized to a 32P-labeled NDRG1-,
NDRG3- or NDRG4-speci¢c probe. The expression of tapasin in
DCs was used as a positive control (C; control DCs). B: Mono-
cyte-derived DCs were stimulated with anti-CD40 mAb (1 Wg/ml),
LPS (1 Wg/ml), TNF-K (100 ng/ml), IFN-Q (1000 U/ml) or IL-1L (10
ng/ml) for 16 h. Total RNA isolated from unstimulated or stimu-
lated DCs was hybridized to 32P-labeled NDRG1, NDRG3 or
NDRG4 probe. C: DCs were treated for the indicated times with
LPS (1 Wg/ml). Total RNA was prepared and Northern blotting
was performed with the NDRG2-speci¢c probe. D: DCs were
treated for the indicated times with actinomycin D (0.1 Wg/ml).
E: DCs were cultured with LPS (1 Wg/ml) alone or with actinomy-
cin D (0.1 Wg/ml) pretreatment (1 h). Cultures were harvested after
12 h and total RNA was prepared and analyzed by Northern blot
hybridization for NDRG2 mRNA levels.
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Interestingly, LPS, unlike other stimuli that induce DC
maturation, predominately down-regulated NDRG2 mRNA.
This down-regulation by LPS and the gradual induction of
NDRG2 expression during DC di¡erentiation make it un-
likely that NDRG2 expression is regulated by NF-UB activa-
tion, which is known to be involved in DC di¡erentiation and
maturation. We hypothesized that the decreased amounts of
NDRG2 mRNA observed after LPS treatment might be due
to the decrease of mRNA stability resulting in the down-reg-
ulation of NDRG2 mRNA. In fact, actinomycin D pretreat-
ment was found to prevent NDRG2 mRNA degradation, as
compared to DCs treated with LPS alone. Thus, the down-
regulation of NDRG2 mRNA by LPS is probably due to the
decrease of mRNA stability induced by LPS treatment. Fur-
thermore, we observed that LPS primarily a¡ected NDRG2
gene expression, but not NDRG1 or NDRG3 gene expres-
sion, in DCs.
In conclusion, we demonstrate in this report that though
the exact function of the NDRG2 gene remains to be estab-
lished, it might be involved in the process of DC di¡erentia-
tion of monocytes, CD34þ precursor and leukemia cells.
Strong NDRG2 gene expression was observed in DCs and
was associated with the cellular di¡erentiation of precursor
cells. This expression pattern was not observed in other mem-
bers of the NDRG family gene. Moreover, NDRG2 gene
expression was di¡erentially regulated by maturation-inducing
stimuli. Therefore, we speculate that understanding the exact
functions of NDRG2 may produce a deeper understanding of
the DC di¡erentiation process and DC-speci¢c functions.
Acknowledgements: We thank Drs. K.Y. Oh and M.H. Park at the
School of Medicine, Eulji University for providing isolated cord blood
cells. This work was supported by a KFDA grant (KFDA-03092-
CEL-072) and a grant (M1-0016-00-0027) from the Ministry of Sci-
ence and Technology, South Korea.
References
[1] Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S.,
Liu, Y.J., Pulendran, B. and Palucka, K. (2000) Annu. Rev.
Immunol. 18, 767^811.
[2] Hart, D.N. (1997) Blood 90, 3245^3287.
[3] Ardavin, C. (2003) Nat. Rev. Immunol. 3, 582^590.
[4] De Smedt, T., Pajak, B., Klaus, G.G., Noelle, R.J., Urbain, J.,
Leo, O. and Moser, M. (1998) J. Immunol. 161, 4476^4479.
[5] Manome, H., Aiba, S. and Tagami, H. (1999) Immunology 98,
481^490.
[6] Inaba, K. et al. (1994) J. Exp. Med. 180, 1849^1860.
[7] Ebner, S., Lenz, A., Reider, D., Fritsch, P., Schuler, G. and
Romani, N. (1998) Immunobiology 198, 568^587.
[8] Palucka, K.A., Taquet, N., Sanchez-Chapuis, F. and Gluckman,
J.C. (1998) J. Immunol. 160, 4587^4595.
[9] Hashimoto, S.I., Suzuki, T., Nagai, S., Yamashita, T., Toyoda,
N. and Matsushima, K. (2000) Blood 96, 2206^2214.
[10] Dietz, A.B., Bulur, P.A., Knutson, G.J., Matasic, R. and Vuk-
Pavlovic, S. (2000) Biochem. Biophys. Res. Commun. 275, 731^
738.
[11] Granucci, F. et al. (2001) Nat. Immunol. 2, 882^888.
[12] Huang, Q., Liu, D., Majewski, P., Schulte, L.C., Korn, J.M.,
Young, R.A., Lander, E.S. and Hacohen, N. (2001) Science
294, 870^875.
[13] Ardeshna, K.M., Pizzey, A.R., Devereux, S. and Khwaja, A.
(2000) Blood 96, 1039^1046.
[14] Andreakos, E., Smith, C., Monaco, C., Brennan, F.M., Foxwell,
B.M. and Feldmann, M. (2003) Blood 101, 983^991.
[15] Ting, C.N., Olson, M.C., Barton, K.P. and Leiden, J.M. (1996)
Nature 384, 474^478.
[16] Nutt, S.L., Heavey, B., Rolink, A.G. and Busslinger, M. (1999)
Nature 401, 556^562.
[17] Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J.,
MacDonald, H.R. and Aguet, M. (1999) Immunity 10, 547^558.
[18] Yokota, Y., Mansouri, A., Mori, S., Sugawara, S., Adachi, S.,
Nishikawa, S. and Gruss, P. (1999) Nature 397, 702^706.
[19] Hacker, C. et al. (2003) Nat. Immunol. 4, 380^386.
[20] Spits, H., Couwenberg, F., Bakker, A.Q., Weijer, K. and Uitten-
bogaart, C.H. (2000) J. Exp. Med. 192, 1775^1784.
[21] Schotte, R., Rissoan, M.C., Bendriss-Vermare, N., Bridon, J.M.,
Duhen, T., Weijer, K., Briere, F. and Spits, H. (2003) Blood 101,
1015^1023.
[22] Sallusto, F. and Lanzavecchia, A. (1994) J. Exp. Med. 179, 1109^
1118.
[23] Chomczynski, P. and Mackey, K. (1995) Anal. Biochem. 225,
163^164.
[24] Choi, S. et al. (2000) Clin. Exp. Metastasis 18, 45^50.
[25] Li, J., Schuler-Thurner, B., Schuler, G., Huber, C. and Seliger, B.
(2001) Int. Immunol. 13, 1515^1523.
[26] MacAry, P.A., Lindsay, M., Scott, M.A., Craig, J.I., Luzio, J.P.
and Lehner, P.J. (2001) Proc. Natl. Acad. Sci. USA 98, 3982^
3987.
[27] Sayani, F. et al. (2000) Blood 95, 461^469.
[28] Masterson, A.J. et al. (2002) Blood 100, 701^703.
[29] Piemonti, L., Monti, P., Sironi, M., Fraticelli, P., Leone, B.E.,
Dal Cin, E., Allavena, P. and Di Carlo, V. (2000) J. Immunol.
164, 4443^4451.
[30] Xing, N., Maldorado, M.L., Bachman, L.A., McKean, D.J., Ku-
mar, R. and Gri⁄n, M.D. (2002) Biochem. Biophys. Res. Com-
mun. 297, 645^652.
[31] Qu, X., Zhai, Y., Wei, H., Zhang, C., Xing, G., Yu, Y. and He,
F. (2002) Mol. Cell. Biochem. 229, 35^44.
[32] Zhou, R.H., Kokame, K., Tsukamoto, Y., Yutani, C., Kato, H.
and Miyata, T. (2001) Genomics 73, 86^97.
[33] Kokame, K., Kato, H. and Miyata, T. (1996) J. Biol. Chem. 271,
29659^29665.
[34] Ulrix, W., Swinnen, J.V., Heyns, W. and Verhoeven, G. (1999)
FEBS Lett. 455, 23^26.
[35] Piquemal, D., Joulia, D., Balaguer, P., Basset, A., Marti, J. and
Commes, T. (1999) Biochim. Biophys. Acta 1450, 364^373.
[36] Kurdistani, S.K., Arizti, P., Reimer, C.L., Sugrue, M.M., Aa-
ronson, S.A. and Lee, S.W. (1998) Cancer Res. 58, 4439^4444.
[37] Salnikow, K., Su, W., Blagosklonny, M.V. and Costa, M. (2000)
Cancer Res. 60, 3375^3378.
[38] Salnikow, K., Kluz, T., Costa, M., Piquemal, D., Demidenko,
Z.N., Xie, K. and Blagosklonny, M.V. (2002) Mol. Cell. Biol. 22,
1734^1741.
[39] Shimono, A., Okuda, T. and Kondoh, H. (1999) Mech. Dev. 83,
39^52.
[40] Ohki, T., Hongo, S., Nakada, N., Maeda, A. and Takeda, M.
(2002) Dev. Brain Res. 135, 55^63.
[41] Neumann, M., Fries, H., Scheicher, C., Keikavoussi, P., Kolb-
Maurer, A., Brocker, E., Ser£ing, E. and Kampgen, E. (2000)
Blood 95, 277^285.
[42] Verhasselt, V., Vanden Berghe, W., Vanderheyde, N., Willems,
F., Haegeman, G. and Goldman, M. (1999) J. Immunol. 162,
2569^2574.
[43] O’Sullivan, B.J. and Thomas, R. (2002) J. Immunol. 168, 5491^
5498.
[44] Boulkroun, S., Fay, M., Zennaro, M.C., Escoubet, B., Jaisser, F.,
Blot-Chabaud, M., Farman, N. and Courtois-Coutry, N. (2002)
J. Biol. Chem. 277, 31506^31515.
FEBS 27679 9-10-03 Cyaan Magenta Geel Zwart
S.-C. Choi et al./FEBS Letters 553 (2003) 413^418418
